Icon

DOJOLVI (nda213687)- (100% w/w)

TRIHEPTANOIN ULTRAGENYX PHARM INC
100% w/w
Yes Yes
2029-Apr-28 2025-Jun-30
None None
None No
DOJOLVI is a medium-chain triglyceride indicated as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).
0 0 0
Total Other Developers 5
Drugs with Suitability No
100% w/w ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.